BioPharm International, March 2023

Process and plasmid design optimization, disposable equipment, and flexible platform processes all play important roles.

Decreasing vein to vein time saves lives.

There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.

Shifts in pharmaceutical packaging have spurred tremendous growth in the pre-filled syringe fill/finish industry.

Considerable efforts have been made over the years to resolve the key issues of stability and delivery of RNA-based therapeutics.

The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines.

The trends shaping the growth of the biologics outsourcing industry demand attention.

Advances in vaccine development are creating partnerships and stimulating clinical trials to develop new mRNA applications.

Good distribution practices ensure appropriate physical storage, distribution, and supply chain security, says Siegfried Schmitt, vice president, Technical, at Parexel.

That wave beginning to crash over PhRMA’s gunwales may well emanate from a startup mindset, rather than Big Pharma or government policy pundits.